"10.1371_journal.pone.0149007","plos one","2016-02-12T00:00:00Z","Björn Vandewalle; Josep M Llibre; Jean-Jacques Parienti; Andrew Ustianowski; Ricardo Camacho; Colette Smith; Alec Miners; Diana Ferreira; Jorge Félix","Exigo Consultores, Lisbon, Portugal; Fundació Lluita contra la SIDA, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Barcelona, Spain; Department of Clinical Research and Biostatistics, Côte de Nacre University Hospital, Caen, France; Regional Infectious Disease Unit, North Manchester General Hospital, Manchester, United Kingdom; Rega Institute for Medical Research, Katholieke Universiteit Leuven, Leuven, Belgium; Department of Infection and Population Health, University College London, London, United Kingdom; Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, United Kingdom","Conceived and designed the experiments: BV JML JJP AU RC CS AM JF. Performed the experiments: BV. Analyzed the data: BV JML JJP AU RC CS AM. Contributed reagents/materials/analysis tools: BV DF JF. Wrote the paper: BV JML JJP AU RC CS AM DF JF.","The authors have the following interests: Gilead contracted with Exigo for the development of the model and its validation using STaR clinical trial data. Gilead also made STaR study data available for external model validation. Björn Vandewalle, Diana Ferreira and Jorge Félix are employed by Exigo Consultores. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2016","02","Björn Vandewalle","BV",9,TRUE,8,1,7,9,TRUE,TRUE,FALSE,0,NA,FALSE
